CDT
Price:
$3.48
Market Cap:
$2.63M
Conduit Pharmaceuticals Inc. operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. It's pipeline includes AZD1656 for the treatment of hashimoto's thyroiditis, renal transplant, uveitis, and preterm labor; and AZD5904 for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.
Industry
Biotechnology
IPO Date
2022-03-28
Stock Exchange
NASDAQ
Ticker
CDT
According to Conduit Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.01. This represents a change of -99.98% compared to the average of -54.87 of the last 4 quarters.
The mean historical PE Ratio of Conduit Pharmaceuticals Inc. over the last ten years is -8160.00. The current -0.01 PE Ratio has changed -99.99% with respect to the historical average. Over the past ten years (40 quarters), CDT's PE Ratio was at its highest in in the September 2023 quarter at 2.46K. The PE Ratio was at its lowest in in the December 2021 quarter at -490228.79.
Average
-8160.00
Median
-2080.92
Minimum
-28479.56
Maximum
1.41
Discovering the peaks and valleys of Conduit Pharmaceuticals Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.47%
Maximum Annual PE Ratio = 1.41
Minimum Annual Increase = -100.00%
Minimum Annual PE Ratio = -28479.56
Year | PE Ratio | Change |
---|---|---|
2024 | 1.41 | -100.00% |
2023 | -28479.56 | 1.47% |
2022 | -1812.71 | -22.84% |
The current PE Ratio of Conduit Pharmaceuticals Inc. (CDT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-10096.95
5-year avg
-8160.00
10-year avg
-8160.00
Conduit Pharmaceuticals Inc.’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Conduit Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Conduit Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Conduit Pharmaceuticals Inc.'s PE Ratio?
How is the PE Ratio calculated for Conduit Pharmaceuticals Inc. (CDT)?
What is the highest PE Ratio for Conduit Pharmaceuticals Inc. (CDT)?
What is the 3-year average PE Ratio for Conduit Pharmaceuticals Inc. (CDT)?
What is the 5-year average PE Ratio for Conduit Pharmaceuticals Inc. (CDT)?
How does the current PE Ratio for Conduit Pharmaceuticals Inc. (CDT) compare to its historical average?